Document is current
Any future updates will be listed below
-
Authors
Li, Jianping
Li, Yan
Koide, Akiko https://orcid.org/0000-0003-1796-7077
Kuang, Huihui
Torres, Victor J. https://orcid.org/0000-0002-7126-0489
Koide, Shohei https://orcid.org/0000-0001-5473-4358
Wang, Da-Neng https://orcid.org/0000-0002-6496-4699
Traaseth, Nathaniel J. https://orcid.org/0000-0002-1185-6088
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI165782, AI108889)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
National Science Foundation (MCB1506420)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS108151)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK135088, DK135088)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM121994, GM121994)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (AI165782, AI165782)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
- License Information
-
More Information
Article History
Received: 10 November 2023
Accepted: 13 May 2024
First Online: 27 May 2024
Competing interests
: A.K., S.K., D.N.W. and N.J.T. are listed as inventors of a patent application filed by New York University on NorA inhibitors (WO2023014970A2). S.K. is a co-founder and holds equity in Aethon Therapeutics and Revalia Bio; has received consulting fees from Aethon Therapeutics and Black Diamond Therapeutics; has received research funding from Aethon Therapeutics, Argenx BVBA, Black Diamond Therapeutics, and Puretech Health, all outside of the current work. V.J.T. is an inventor on patents and patent applications filed by NYU, which are currently under commercial license to Janssen Biotech Inc. Janssen Biotech Inc. has provided research funding and other payments associated with the licensing agreement. The remaining authors declare no competing interests.
